Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Pyatt

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Medical Genetics. Part A|August 5, 2010
Unexpected detection of dystrophin gene deletions by array comparative genomic hybridizationCatherine E Cottrell, Thomas W Prior, Robert Pyatt, et al.
Molecular Genetics & Genomic Medicine|March 25, 2015
A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican HispanicsSamiah A Al-Zaidy, Vinod Malik, Kelley Kneile, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2026
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled TrialLeigha Senter, Shelly Hovick, Rachel Notestine, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Medical Genetics. Part A|August 5, 2010
Unexpected detection of dystrophin gene deletions by array comparative genomic hybridizationCatherine E Cottrell, Thomas W Prior, Robert Pyatt, et al.
Molecular Genetics & Genomic Medicine|March 25, 2015
A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican HispanicsSamiah A Al-Zaidy, Vinod Malik, Kelley Kneile, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2026
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled TrialLeigha Senter, Shelly Hovick, Rachel Notestine, et al.
Pageof 2